
TG Therapeutics, Inc.
USD53.95
-0.01 (-0.02%)
CEO
Michael S. Weiss
IPO Date
2010-05-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$54.24
Prev. Close
$53.96
Day Low
$53.26
Day High
$54.90
52W Low
$25.28
52W High
$59.30
Market Cap
$8.26B
Volume
1.43M
TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis at 7th Congress of the European Academy of Neurology